Stockscreener 앱 받기
8.32
1.84%
0.15
Corbus Pharmaceuticals Holdings Inc 주식(CRBP)의 최신 뉴스
Revenue Check: How is Corbus Pharmaceuticals Holdings Inc managing supply chain issues2025 Geopolitical Influence & Accurate Intraday Trading Signals - baoquankhu1.vn
Corbus Pharmaceuticals Completes $75 Million Public Offering - MSN
CRBP: CRB-701 and CRB-913 advance with strong data, regulatory clarity, and funding into 2028 - TradingView — Track All Markets
Corbus Pharmaceuticals surges on CRB-913 trial success - Intellectia AI
Corbus declines following early-stage results on oral obesity asset CRB-913 - MSN
Market Wrap: Why Corbus Pharmaceuticals Holdings Inc stock could be next big winnerCPI Data & AI Enhanced Trading Signals - Bộ Nội Vụ
Corbus Updates Corporate Outlook, Highlights Diversified 2026 Pipeline - TipRanks
Published on: 2026-01-12 10:26:56 - Улправда
Why Corbus Pharmaceuticals Holdings Inc. stock could outperform in 2025Gap Up & Weekly Top Performers Watchlists - Улправда
The 3 Best Cannabis Stocks to Buy for 2026 - Yahoo Finance
Will Corbus Pharmaceuticals Holdings Inc. stock continue upward momentumMarket Trend Review & Weekly Top Gainers Trade List - Улправда
Will Corbus Pharmaceuticals Holdings Inc. (3371) stock sustain dividend payoutsJuly 2025 Retail & Free Verified High Yield Trade Plans - Улправда
Aug Outlook: Will Corbus Pharmaceuticals Holdings Inc. stock continue upward momentum - Улправда
Corbus Pharmaceuticals (NASDAQ:CRBP) Share Price Crosses Below 50 Day Moving AverageHere's Why - MarketBeat
Corbus Pharmaceuticals Holdings Inc. stock underperforms Wednesday when compared to competitors despite daily gains - MarketWatch
News | postregister.comCorbus Pharmaceuticals Holdings, Inc.Common Stock (Nasdaq:CRBP) Detailed Stock Data - FinancialContent
Revenue per share of Corbus Pharmaceuticals Holdings Inc – LSE:0SZI - TradingView — Track All Markets
J.P. Morgan Healthcare Conference - marketscreener.com
Corbus Pharmaceuticals to Present Corporate Overview at the 2026 Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Corbus Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Corbus Pharmaceuticals shares rise on encouraging safety results for experimental obesity drug - MSN
While hedge funds own 24% of Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP), retail investors are its largest shareholders with 46% ownership - Yahoo Finance
Corbus Pharmaceuticals Holdings Inc. stock underperforms Friday when compared to competitors - MarketWatch
Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors on strong trading day - MarketWatch
How Corbus Pharmaceuticals Holdings Inc. (CRBP) Affects Rotational Strategy Timing - Stock Traders Daily
Downgrade Watch: Will Corbus Pharmaceuticals Holdings Inc 3371 stock top growth indexesMarket Growth Summary & Daily Volume Surge Trade Alerts - Bộ Nội Vụ
Corbus Pharmaceuticals (NASDAQ:CRBP) Shares Cross Below Fifty Day Moving AverageShould You Sell? - MarketBeat
Corbus Pharmaceuticals Holdings Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Corbus Pharmaceuticals announces retirement of board member Holmer - MSN
Can Corbus Pharmaceuticals Holdings Inc. stock sustain institutional interest2025 EndofYear Setup & Fast Exit and Entry Trade Guides - DonanımHaber
Will Corbus Pharmaceuticals Holdings Inc. stock outperform growth indexesQuarterly Trade Review & Growth-Oriented Investment Plans - DonanımHaber
Will Corbus Pharmaceuticals Holdings Inc. stock outperform value stocksJuly 2025 Drop Watch & Consistent Return Strategy Ideas - DonanımHaber
Can Corbus Pharmaceuticals Holdings Inc. stock continue upward trendJuly 2025 PreEarnings & Free Reliable Trade Execution Plans - DonanımHaber
Corbus Pharmaceuticals Announces Retirement of Board Member Holmer - The Globe and Mail
How resilient is Corbus Pharmaceuticals Holdings Inc. stock in market downturnsJuly 2025 Sector Moves & AI Based Trade Execution Alerts - Улправда
Will Corbus Pharmaceuticals Holdings Inc. stock return to pre crisis levelsJuly 2025 Update & Entry and Exit Point Strategies - Улправда
Volume Report: How resilient is Corbus Pharmaceuticals Holdings Inc. stock in market downturnsPortfolio Gains Report & Growth Oriented Trade Recommendations - ulpravda.ru
Cormorant Asset Management, LP Reduces Stake in Corbus Pharmaceu - GuruFocus
Corbus Pharmaceuticals (CRBP) director Alan Holmer resigns from board to retire - Stock Titan
Corbus Pharmaceuticals Holdings, Inc. Announces Resignation of Alan Holmer from its Board of Directors, Effective December 31, 2025 - marketscreener.com
Rally Mode: How resilient is Corbus Pharmaceuticals Holdings Inc. stock in market downturnsJuly 2025 EndofMonth & Free Expert Verified Stock Movement Alerts - Улправда
Corbus Pharmaceuticals Holdings Inc. Stock Slides 8.6%, Underperforms Peers - 富途牛牛
Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Wednesday When Compared To Competitors - 富途牛牛
Cormorant Asset Management, Lp Sells 30,029 Shares of Corbus Pharmaceuticals (NASDAQ:CRBP) Stock - MarketBeat
Corbus Pharmaceuticals (CRBP) insider reports 30,029-share stock sale - Stock Titan
Discipline and Rules-Based Execution in CRBP Response - Stock Traders Daily
Corbus Pharmaceuticals Holdings Inc. (CRBP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CRBP stock surged 36% pre-market – what did its obesity treatment drug study reveal? - MSN
Corbus Pharmaceuticals (CRBP) Reports Phase 1 Study Results for Obesity Drug - GuruFocus
Corbus Pharmaceuticals Holdings Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Corbus declines following early-stage results on oral obesity asset CRB-913 (CRBP:NASDAQ) - Seeking Alpha
CRBP Stock Surged 36% Pre-Market – What Did Its Obesity Treatment Drug Study Reveal? - Stocktwits
4.73%
0.92%
자본화:
|
볼륨(24시간):